The MFN Rule could dramatically restrict patient access to infusion medications administered in physician offices, especially for patients with Crohn’s disease and ulcerative colitis, which are both major categories of inflammatory bowel disease (IBD).
Continue Reading >>
Archives for November 2020
DHPA Supports USPSTF Recommendations to Begin CRC Screening at 45, Calls for More Research on Disparities in Communities of Color
While supporting the draft recommendations overall, Dr. Glenn Littenberg, DHPA chair of health policy, expressed some concern about USPSTF’s recommendations with respect to screening colonoscopy versus stool-based CRC screening.
Continue Reading >>